Selected publications of a total of 165. IF: Impact Factor year of publication, Q1 (quartil 1) D1 (decil 1)(JCR en Web of Science de Thompson Reuters). More information related to publications at www.ncbi.nlm.nih.gov/pubmed/?term=Palomares+O and ORCID ID: orcid.org/0000-0003-4516-0369

1. Sevilla-Ortega C, Angelina A, Martín-Cruz L, Pérez-Diego M, Maldonado A, Lavín B, Marcos-Ramiro B, Pérez de Llano L, Gayá A, Real FX, Conejero L, Subiza JL, Palomares O* (2025).A mucosal vaccine prevents eosinophilic allergic airway inflammation by modulating immune responses to allergens in a murine model of airway disease. Nat Commun; 3;16(1):7129. doi: 10.1038/s41467-025-62632-x. IF: 15.7, D1.

2. Pérez-Diego M, Angelina A, Pat Y, Maldonado A, Sevilla-Ortega C, Martín-Cruz L, Yazici D, Rückert B, Sokolowska M, Martín-Fontecha M, Akdis M, Akdis CA, Palomares O* (2025). Cannabinoid WIN55,212-2 restores bronchial epithelium by regulating oxidative stress and STAT6 phosphorylation. J Allergy Clin Immunol; 16:S0091-6749(25)00551-2. IF: 10.5, D1.

3. de la Rocha-Muñoz A, Benito-Villalvilla C, Olivares D, Sirvent S, García-Brenes MA, Angelina A, Martín-Cruz L, Cuesta J, Tassinari P, Jaumont X, Taxonera C, Palomares O* (2025). The Role of IgE in Crohn’s Disease by Impairing the Capacity of Plasmacytoid Dendritic Cells to Generate FOXP3+ Tregs. Allergy; doi: 10.1111/all.16517. IF: 12.6, D1.

4. Martín-Cruz L, Palomares O* (2025). Allergen-Specific Immunotherapy and Trained Immunity. Allergy; doi: 10.1111/all.16423. IF: 12.6, D1.

5. Martín-Cruz L, Benito-Villalvilla C, Angelina A, Subiza JL, Palomares O* (2024). Trained Immunity-based vaccines for infections and allergy. J Allergy Clin Immunol. 154:1085-1094. IF: 11.4, D1.

6. Martín-Cruz L, Viñuela M, Kalograiaki I, Angelina A, Oquist-Phillips P, Real-Arévalo I, Cañada FJ, Tudela JI, Moltó L, Moreno J, Subiza JL, Palomares O* (2023). A tumor-associated heparan sulfate-related glycosaminoglycan promotes the generation of functional regulatory T cells. Cell Mol Immunol. 20:1499-1512. IF: 21.8, D1.

7. Kolkhir P, Akdis CA, Akdis M, Bachert C, Bieber T, Canonica GW, Guttman-Yassky E, Metz M, Mullol J, Palomares O, Renz H, Ständer S, Zuberbier T, Maurer M (2023). Type 2 chronic inflammatory diseases: targets, therapies and unmet needs. Nat Rev Drug Discov. 22:743-767. IF: 122.7, D1.

8. Benito-Villalvilla C, de la Rocha A, López J, Eggel A, Bottoli I, Severin T, Woisetschläger M, Palomares O* (2023). Ligelizumab impairs IgE-binding to plasmacytoid DCs more potently than omalizumab and restores IFN-α production and FOXP3+ Treg generation. Allergy. 78:1060-1072. IF: 12.6, D1.

9. Pérez-Diego M, Angelina A, Martín-Cruz L, de la Rocha-Muñoz A, Maldonado A, Sevilla-Ortega C, Palomares O* (2023). Cannabinoid WIN55,212-2 reprograms monocytes and macrophages to inhibit LPS-induced inflammation. Front Immunol. 16;14:1147520. IF: 7.3, Q1.

10. Martín-Cruz L, Angelina A, Baydemir I, Bulut Ö, Subiza JL, Netea MG, Domínguez-Andrés J, Palomares O* (2022). Candida albicans V132 induces trained immunity and enhances the responses triggered by the polybacterial vaccine MV140 for genitourinary tract infections. Front Immunol. 24;13:1066383. doi: 10.3389/fimmu.2022.1066383. IF: 6.4, Q1.

11. Angelina A, Jiménez R, Pérez M, Maldonado A, Rückert B, Akdis M, Martín-Fontecha M, Akdis CA, Palomares O* (2022). Cannabinoid WIN55212-2 impairs peanut-allergic sensitization and promotes the generation of allergen-specific regulatory T cells. Clin Exp Allergy. 52:540-549. IF: 6.1, Q1.

12. Angelina A, Pérez-Diego M, López-Abente J, Rückert B, Nombela I, Akdis M, Martín-Fontecha M, Akdis C, Palomares O* (2022). Cannabinoids induce functional Tregs by promoting tolerogenic DCs via autophagy and metabolic reprograming. Mucosal Immunol. 15:96-108. IF: 8.0, Q1.

13. Benito-Villalvilla, C., Pérez-Diego, M., Angelina, A., Kisand, K., Rebane, A., Subiza, J. L., Palomares, O* (2022). Allergoid-mannan conjugates reprogram monocytes into tolerogenic DCs via epigenetic and metabolic rewiring. J Allergy Clin Immunol. S0091-6749(21)00968-4. FI: 14.2, D1.

14. Angelina A, Pérez-Diego M, Maldonado A, Rückert B, Akdis M, Martín-Fontecha M, Akdis CA, Palomares O* (2021). The cannabinoid WIN55212-2 suppresses effector T cell responses and promotes regulatory T cells in human tonsils. Allergy. doi: 10.1111/all.15160. IF: 13.2, D1.

15. Benito-Villalvilla C, Pérez-Diego M, Subiza JL, Palomares O* (2021). Allergoid-mannan conjugates imprint tolerogenic features in human macrophages. Allergy. doi: 10.1111/all.15118. IF: 13.2, D1.

16. López-Abente J, Benito-Villalvilla C, Jaumont X, Pfister P, Tassinari P, Palomares O* (2021). Omalizumab restores the ability of human plasmacytoid dendritic cells to induce Foxp3+Tregs. Eur Respir J. 57(1):2000751. FI: 24.9, D1.

17. Martin-Cruz L, Sevilla-Ortega C, Benito-Villalvilla C, Diez‐Rivero CM, Sanchez-Ramón S, Subiza JL, Palomares O* (2021). A Combination of Polybacterial MV140 and Candida albicans V132 as a Potential Novel Trained Immunity-Based Vaccine for Genitourinary Tract Infections. Front Immunol. 11:3528. doi:10.3389/fimmu.2020.612269. IF: 7.6, Q1.

18. Angelina A, Martín-Fontecha M, Rückert B, Wawrzyniak P, Pérez-Diego M, López-Abente J, Akdis M, Akdis CA, Palomares O* (2020). The cannabinoid WIN55212-2 restores rhinovirus-induced epithelial barrier disruption. Allergy. doi: 10.1111/all.14707. IF: 13.2, D1.

19. Benito-Villalvilla C, Soria I, Pérez-Diego M, Fernández-Caldas E, Subiza JL, Palomares O* (2020). Alum impairs tolerogenic properties induced by allergoid-mannan conjugates inhibiting mTOR and metabolic reprogramming in human DCs. Allergy. 75(3):648-659. doi: 10.1111/all.14036. IF: 13.146, D1.

20. Bousquet J., Anto J.M., Bachert C., Baiardini I., Bosnic-Anticevich S., Walter Canonica G., Melén E., Palomares, O., Scadding G.K., Togias A., Toppila-Salmi, S. (2020). Allergic rhinitis. Nat Rev Dis Primers. doi: 10.1038/s41572-020-00227-0. IF: 40.689, D1.

21. Cirauqui C., Benito-Villalvilla C., Sánchez-Ramón S., Sirvent S., Diez-Rivero C.M., Conejero L., Brandi P., Hernández-Cillero L., Ochoa J.L., Pérez-Villamil B., Sancho D., Subiza J.L., Palomares O* (2018). Human dendritic cells activated with MV130 induce Th1, Th17 and IL-10 responses via RIPK2 and MyD88 signalling pathways. Eur J Immunol. 48:180-193. IF: 4.2, Q1.

22. Benito-Villalvilla, C., Cirauqui, C., Diez-Rivero, C.M., Casanovas, M., Subiza, J.L., Palomares, O* (2017). MV140, a sublingual polyvalent bacterial preparation to treat recurrent urinary tract infections, licenses human dendritic cells for generating Th1, Th17, and IL-10 responses via Syk and MyD88. Mucosal Immunol. 2017;10:924-935. IF: 7.5, Q1.

23. Sirvent S, Soria I, Cirauqui C, Cases B, Manzano AI, Diez-Rivero CM, Reche PA, López-Relaño J, Martínez-Naves E, Cañada FJ, Jiménez-Barbero J, Subiza J, Casanovas M, Fernández-Caldas E, Subiza JL, Palomares O* (2016). Novel vaccines targeting dendritic cells by coupling allergoids to non-oxidized mannan enhance allergen uptake and induce functional regulatory T cells via PD-L1. J Allergy Clin Immunol. 138(2):558-567.e11. IF: 12.5, D1.

24. Angelina A, Sirvent S, Palladino C, Vereda A, Cuesta-Herranz J, Eiwegger T, Rodríguez R, Breiteneder H, Villalba M, Palomares O*. (2016). The lipid-interaction capacity of Sin a 2 and Ara h 1, major mustard and peanut allergens of the cupin superfamily, endorses allergenicity. Allergy. 71(9):1284-94. IF: 6.0, Q1.

25. Sirvent, S., Cantó, B., Gómez, F., Blanca, N., Cuesta-Herranz, J., Canto, G., Blanca, M., Rodríguez, R., Villalba, M., Palomares, O.* (2014). Detailed characterization of Act d 12 and Act d 13 from kiwi seeds: implication in IgE cross-reactivity with peanut and tree nuts. Allergy. 69(11):1481-8. IF: 6.0, Q1.

26. Sirvent, S., Cantó, B., Cuesta-Herranz, J., Gómez, F., Blanca, N., Canto, G., Blanca, M., Rodríguez, R., Villalba, M., Palomares, O.* (2014). Act d 12 and Act d 13: Two novel, masked, relevant allergens in kiwifruit seeds. J Allergy Clin Immunol. 133:1765-7.e4. IF: 11.3, D1. Interview of Dr. Sicherer, Associate Editor of JACI, to Dr. Palomares in: http://www.youtube.com/watch?v=fS40RwdS1jY#t=17.

27. Martín-Fontecha, M., Eiwegger, T., Jartti, T., Rueda-Zubiaurre A., Tiringer K., Stepanow J., Puhakka, T., Rückert, B., Ortega-, S., López-Rodríguez, M.L., Akdis, M., Akdis C.A., Palomares O.* (2014). The expression of cannabinoid receptor 1 is signficantly increased in atopic patients. J Allergy Clin Immunol. 133:926-29.e2. IF: 11.3, D1.

28. Palomares, O.*, Rückert, B., Jartti, T., Kücüksezer, U., Puhakka, T. Gomez E., Fahrner H.B., Speiser, A., Jung, A., Kwok W.,W., Kalogjera L., Akdis, M.,Akdis, C.A.* (2012). Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tosils as first line organs of oral tolerance. J Allergy Clin Immunol. 129:510-20.e1-9. IF: 12.1, D1.

29. Palomares, O., Yaman, G., Azkur, A.K., Akkoc, T., Akdis, M., Akdis, C. (2010). Role of T regulatory cells in immune regulation of allergic diseases. Eur J Immunol. 40:1232-40. FI: 5.0, Q1.

30. Klunker, S., Chong, M. M. W., Mantel, P. Y., Palomares, O., Bassin, C., Ziegler, M., Rückert, B., Meiler, F., Akdis, M., Littman, D. R., Akdis, C.A. (2009). Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells. J Exp Med. 206:2701-15. FI: 14.5, D1.

31. Palomares, O., Alcántara, M., Quiralte, J., Villalba, M., Garzón, F., Rodríguez, R (2008). A thaumatin-like protein and occupational airway disease in an olive-oil mill worker. N Engl J Med. 358:1306-8. IF: 50.1, D1.